专题:PI3K/AKT/mTOR signaling in cancer

This cluster of papers focuses on the mTOR signaling pathway, particularly its role in growth control, metabolism, and disease, with a specific emphasis on cancer. The PI3K/AKT pathway, Raptor, TSC2, and rapamycin are central to the research discussed in these papers.
最新文献
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update

review Full Text OpenAlex

Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer

review Full Text OpenAlex

Cardiovascular toxicity of Bruton tyrosine kinase inhibitors: forget about selectivity but watch the clock

letter Full Text OpenAlex

Insights into Clinical Disorders in Cowden Syndrome: A Comprehensive Review

review Full Text OpenAlex

Exploring tonsil pathology in PTEN hamartoma syndrome: a cohort study

article Full Text OpenAlex

Wogonin Inhibits Colorectal Cancer Proliferation and Epithelial Mesenchymal Transformation by Suppressing Phosphorylation in the AKT Pathway

article Full Text OpenAlex

Desmethylclomipramine triggers mitochondrial damage and death in TGF-β-induced mesenchymal type of A549 cells

article Full Text OpenAlex

Regulation of YAP translocation by myeloid Pten deficiency alleviates acute lung injury via inhibition of oxidative stress and inflammation

article Full Text OpenAlex

IRTKS promotes osteogenic differentiation by inhibiting PTEN phosphorylation

article Full Text OpenAlex

Functional characterization of PI3K C2 domain mutations detected in breast cancer circulating tumor cells and metastatic cells

article Full Text OpenAlex

近5年高被引文献
Targeting PI3K/Akt signal transduction for cancer therapy

review Full Text OpenAlex 1428 FWCI76.27035811

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

review Full Text OpenAlex 1382 FWCI256.96784416

Kinase drug discovery 20 years after imatinib: progress and future directions

review Full Text OpenAlex 948 FWCI142.58391616

Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRAS G12C Mutation

article Full Text OpenAlex 817 FWCI101.0397787

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

review Full Text OpenAlex 682 FWCI85.90227227

Regulation and metabolic functions of mTORC1 and mTORC2

review Full Text OpenAlex 675 FWCI48.86374605

Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

review Full Text OpenAlex 621 FWCI115.67266396

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

review Full Text OpenAlex 596 FWCI38.03764663

Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer

article Full Text OpenAlex 521 FWCI176.44711745

PI3K inhibitors are finally coming of age

review Full Text OpenAlex 437 FWCI36.18453051